NASDAQ: RPRX       Royalty Pharma Plc Cl A
Last Price Today's Change   Day's Range   Trading Volume
45.94   -0.53 (1.14%)  45.80 - 48.68  336,591


Avg Volume (4 weeks):5,936,616
4 Weeks Range:42.00 - 56.50
4 Weeks Price Volatility (%):
52 Weeks Range:42.00 - 56.50
52 Weeks Price Volatility (%):
Average Price Target: 35.00
Price Target Upside/Downside: -10.94


No recent Headlines for this stock.

Business Background

Repros Therapeutics, Inc. is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. The Company's product candidates include enclomiphene, which is a single isomer of clomiphene citrate, an orally active small molecule compound, and Proellex, which is an orally administered selective blocker of the progesterone receptor in women, for the treatment of uterine fibroids and endometriosis. Enclomiphene is for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function. The Company's Proellex product candidate for female reproductive health is a chemical entity, which acts as a selective blocker of the progesterone receptor. It is being developed for the treatment of symptoms associated with uterine fibroids and endometriosis The Company has an active Investigational New Drug (IND) for the vaginal delivery of Proellex for the treatment of uterine fibroids.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2438  3234  396  2996 

Top 10 Active Counters
 LK 1.38-1.62 
 NIO 9.005+1.095 
 AVP 5.60-0.05 
 WKHS 20.925+1.745 
 AABA 19.630.00 
 SOLO 3.025+0.695 
 TGE 22.39+0.81 
 APY 10.34+0.25 
 AKRX 0.09-0.094 
 PGNX 4.10-0.425 
Partners & Brokers